Sight Sciences Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 214

Employees

  • Stock Symbol
  • SGHT

Stock Symbol

  • Share Price
  • $2.71
  • (As of Thursday Closing)

Sight Sciences General Information

Description

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 4040 Campbell Avenue
  • Suite 100
  • Menlo Park, CA 94025
  • United States
+1 (877)
Primary Industry
Surgical Devices
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 4040 Campbell Avenue
  • Suite 100
  • Menlo Park, CA 94025
  • United States
+1 (877)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sight Sciences Stock Performance

As of 06-Feb-2025, Sight Sciences’s stock price is $2.71. Its current market cap is $137M with 50.4M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.71 $2.87 $2.67 - $8.45 $137M 50.4M 230K -$1.01

Sight Sciences Financials Summary

As of 30-Sep-2024, Sight Sciences has a trailing 12-month revenue of $79.5M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 233,784 141,723 422,445 593,867
Revenue 79,543 81,056 71,331 48,956
EBITDA (44,597) (49,415) (81,019) (57,774)
Net Income (50,352) (55,547) (86,242) (62,960)
Total Assets 143,597 166,651 213,073 280,186
Total Debt 35,285 35,414 34,981 34,206
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sight Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sight Sciences‘s full profile, request access.

Request a free trial

Sight Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Sight Sciences‘s full profile, request access.

Request a free trial

Sight Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical
Surgical Devices
Menlo Park, CA
214 As of 2023

Aliso Viejo, CA
 

Kent Town, Australia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sight Sciences Competitors (10)

One of Sight Sciences’s 10 competitors is Glaukos, a Formerly VC-backed company based in Aliso Viejo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Glaukos Formerly VC-backed Aliso Viejo, CA
Nova Eye Medical Corporation Kent Town, Australia
MicroSurgical Technology Corporate Backed or Acquired Redmond, WA
Alcon Corporate Backed or Acquired Geneva, Switzerland
New World Medical Corporation Rancho Cucamonga, CA
You’re viewing 5 of 10 competitors. Get the full list »

Sight Sciences Patents

Sight Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12213914-B2 Ocular delivery systems and methods Active 30-Nov-2023
US-20240173251-A1 Bio-erodible ocular implants for treatment of conditions of the eye Pending 28-Nov-2022
US-20240225894-A1 Ocular delivery systems and methods Pending 23-Aug-2022
US-20230293347-A1 Devices and methods for intraocular tissue manipulation Pending 16-Mar-2022
US-20230293346-A1 Devices and methods for intraocular tissue manipulation Active 16-Mar-2022 A61F9/00772
To view Sight Sciences’s complete patent history, request access »

Sight Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sight Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sight Sciences‘s full profile, request access.

Request a free trial

Sight Sciences ESG

Risk Overview

Risk Rating

Updated September, 01, 2023

30.83 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,120

Rank

Percentile

Healthcare

Industry

of 587

Rank

Percentile

Medical Devices

Subindustry

of 199

Rank

Percentile

To view Sight Sciences’s complete esg history, request access »

Sight Sciences FAQs

  • When was Sight Sciences founded?

    Sight Sciences was founded in 2010.

  • Where is Sight Sciences headquartered?

    Sight Sciences is headquartered in Menlo Park, CA.

  • What is the size of Sight Sciences?

    Sight Sciences has 214 total employees.

  • What industry is Sight Sciences in?

    Sight Sciences’s primary industry is Surgical Devices.

  • Is Sight Sciences a private or public company?

    Sight Sciences is a Public company.

  • What is Sight Sciences’s stock symbol?

    The ticker symbol for Sight Sciences is SGHT.

  • What is the current stock price of Sight Sciences?

    As of 06-Feb-2025 the stock price of Sight Sciences is $2.71.

  • What is the current market cap of Sight Sciences?

    The current market capitalization of Sight Sciences is $137M.

  • What is Sight Sciences’s current revenue?

    The trailing twelve month revenue for Sight Sciences is $79.5M.

  • Who are Sight Sciences’s competitors?

    Glaukos, Nova Eye Medical, MicroSurgical Technology, Alcon, and New World Medical are some of the 10 competitors of Sight Sciences.

  • What is Sight Sciences’s annual earnings per share (EPS)?

    Sight Sciences’s EPS for 12 months was -$1.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »